L26/P-264 Selection of euploid blastocysts for transfer: impact of mitochondrial DNA content, day of biopsy and embryo morphokinetics on implantation and live birth outcomes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Desai und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Are there specific blastocyst attributes that can be used to identify euploid blastocysts with higher implantation potential? Summary answer When selecting a single euploid blastocyst for transfer, kinetics of blastulation and day of biopsy are strongly associated with live birth potential. What is known already Despite widespread use of preimplantation genetic testing for aneuploidy (PGT-A),not all blastocysts diagnosed as euploid implant. Blastocyst morphology and developmental timing guide embryo selection in non-PGT cycles, but their effect on live birth rates after euploid blastocyst transfer remains uncertain. Mitochondrial DNA copy number as represented by Mitoscore (MT) can serve as a marker of energetic stress in the developing embryo. Increases in mitochondrial biogenesis during early development and in resultant blastocysts may result in lower implantation potential. MT has therefore been proposed as an additional tool for ranking euploid blastocysts. Study design, size, duration Frozen embryo transfers with a single euploid blastocyst occurring between January 2021 and February 2025 February were retrospectively reviewed. All embryos for FET were originally cultured in the Embryoscope. Trophectoderm biopsies were performed on day 5 (D5) at 114-120 hrs post-insemination (hpi) and on day 6 (D6; 138 -144 hpi) prior to embryo vitrification. Morphokinetic data from pre-freeze were collected for each transferred blastocyst. Participants/materials, setting, methods Data from 704 FET cycles were analyzed. Variables assessed were biopsy day, morphokinetic parameters, embryo dysmorphisms, Mitoscore and blastocyst quality. Inner cell mass (ICM) and trophectoderm (TE) morphology were graded (1-good, 2-fair, 3-poor). Blastocysts were also grouped by MT values: MT1 <20, MT2 20-25, MT3 >25-30, MT4 >30. Primary outcomes were clinical pregnancy (CP) and live birth (LB). Data were analyzed using Chi square tesst and ANOVA . Multivariate analysis was also performed. Main results and the role of chance The positive hCG, clinical pregnancy (CPR) and live birth rates (LBR) were 75.1% ,66.1% and 62.1%, respectively. Euploid blastocysts derived from biopsies performed by 120 hpi on D5 resulted in significantly higher clinical outcomes (CPR 71.0%, LBR 67%; p = 0.0005) compared to embryos cultured to day 6 (CPR 57.6%; LBR 53.8%). CPR based on ICM grade alone were: ICM1, 70.7%, ICM2, 63.3% and ICM3, 49.1%; p = 0.003). CPR based on TE grade were: TE1, 73.3%, TE2, 63.4% and TE3, 37.5% (p < 0.0001). Morphokinetic parameter tEB-tSB < =13 was also independently associated with pregnancy (73.3%; p = 0.02). No differences were detected in LBR with Mitoscore: MT1, 63.5%, MT2, 64.9%, MT3 59.0% and MT 4, 59.5%). With logistic regression analysis for LB, the AUC was 0.61 (p < 0.0001) by including biopsy day, TE and ICM in the model. Odds ratio (OR) for LB with D5 vs D6 BL was 1.69 (CI 1.21,2.39; p = 0.002). Odds of LB with TE 1 vs 2 ,was 1.49 (CI 1.06,2.1; p = 0.02). With TE 1 v 3, odds of LB were 3-fold higher (OR 3.3; CI 1.69, 6.72; p = 0.0005). For D6 blastocyst selection, including tEB-tSB < =13, TE and ICM in the model resulted in an AUC for LB of 0.70 (p=.0005). Limitations, reasons for caution The retrospective nature of this study is a limitation in constructing a robust model for euploid embryo selection. Unlike in previous reports, inclusion of Mitoscore in embryo evaluation did not increase discriminatory ability in selecting amongst euploid blastocysts. Mitoscore’s usefulness for embryo ranking should therefore be critically evaluated before application. Wider implications of the findings Blastocysts diagnosed as euploid can differ significantly in implantation potential. Proper ranking and selection may shorten time to pregnancy. Odds of pregnancy and live birth can be significantly increased by first preferentially selecting euploid blastocysts from D5 versus D6 biopsies and focusing on those with the highest scoring TE grade. Trial registration number No
Zitieren
APA
Desai, N., Wirtjes, M., Falcone, T., & Christianson, M. (2026). L26/P-264 Selection of euploid blastocysts for transfer: impact of mitochondrial DNA content, day of biopsy and embryo morphokinetics on implantation and live birth outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.600
Vancouver
Desai N, Wirtjes M, Falcone T, Christianson M. L26/P-264 Selection of euploid blastocysts for transfer: impact of mitochondrial DNA content, day of biopsy and embryo morphokinetics on implantation and live birth outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.600
BibTeX
@article{Desai2026,
author = {Desai, N. and Wirtjes, M. and Falcone, T. and Christianson, M.},
title = {L26/P-264 Selection of euploid blastocysts for transfer: impact of mitochondrial DNA content, day of biopsy and embryo morphokinetics on implantation and live birth outcomes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.600}
}
EUVIMED